Objective-Aberrant blood-brain barrier (BBB) permeability is a hallmark pathology of many central nervous system diseases. von Willebrand factor (VWF) is stored in endothelial Weibel-Palade bodies from where it is released on activation into plasma and basement membrane. The role of VWF in endothelial homeostasis is unclear. The goal of this study was to assess the role of VWF in disease models associated with increased BBB permeability. Approach and Results-We did not find any differences in BBB permeability to Evans blue dye at baseline between wildtype and VWF −/− animals. We next used 2 models presenting with increased BBB permeability, hypoxia/reoxygenation and pilocarpine-induced status epilepticus, to assess the response of VWF −/− animals. In both models, VWF −/− mice maintained a tighter BBB than wild-type mice. VWF −/− mice fared worse in both conditions, with ≈100% of VWF −/− mice dying within 120 minutes after pilocarpine administration, whereas >80% of wild-type animals survived. Investigation into the status of tight junction proteins revealed that VWF −/− mice expressed more claudin-5 at baseline. In vitro work confirmed that the presence of subendothelial VWF is inhibitory to claudin-5 expression. Conclusions-VWF deficiency confers partial preservation of BBB integrity after hypoxia/reoxygenation and seizures.
B
lood-brain barrier (BBB) opening is a hallmark of many pathological conditions of the central nervous system, including hypoxia, epilepsy, multiple sclerosis, and ischemic stroke. [1] [2] [3] [4] [5] Although it is known that von Willebrand factor (VWF) is expressed abundantly by cerebral endothelial cells, 6 very little is known about the role of VWF, in general, and the regulation of BBB, in particular. VWF is a glycoprotein that is only synthesized by endothelial cells and megakaryocytes. 7 Endothelial cell-derived VWF is secreted constitutively and stored in Weibel-Palade bodies (WPBs) from where it is released by regulated secretion into the plasma and basement membrane in response to endothelial activation. 8 Interestingly, studies have shown that VWF protein is upregulated in the plasma of patients with neurological conditions as diverse as stroke, 9 severe head injury, 10 cerebral malaria, 11 and cerebral venous sinus thrombosis. 12 Although it has been published that all these conditions involve BBB disruption, there has been very little literature examining the potential role of VWF in BBB regulation under pathological conditions. Interestingly, a role for endothelial VWF in regulation of angiogenesis has recently been reported, indicating that it may play a role in endothelial biology. 13 To study the role of VWF in conditions associated with increased BBB permeability, we subjected wild-type (WT) and VWF −/− mice to 2 models: hypoxia/reoxygenation (H/R) and pilocarpine-induced status epilepticus (SE). Generalized normobaric hypoxia is a pathological condition in which the body as a whole is deprived of adequate oxygen supply. Hypoxia occurs in healthy people when they ascend to high altitudes where it can cause altitude sickness, often manifested by headache, leading to potentially fatal complications, such as high-altitude cerebral edema. 14, 15 Hypoxia followed by reoxygenation is also commonly used as a model to investigate pathology associated with ischemia/reperfusion, because the latter condition is present in several disease states, including stroke. 16 Epilepsy is a neurological disease afflicting 1.2% to 3% of the general population. 17, 18 Symptomatic epilepsy is associated with a higher risk for death compared with the general population. 19 Death commonly occurs during SE, which is defined as a prolonged seizure state with no return to normal state of consciousness lasting ≥30 minutes and has a mortality rate of 20% to 40%. Several triggers of SE have been identified, such as hypoxia, infection, and trauma, and a complete mechanism of SE is unknown. [20] [21] [22] SE can be closely mimicked by intraperitoneal injection of pilocarpine, a model that was developed decades ago. [23] [24] [25] This model first presents with an instantaneous period of SE followed by a latent period and, in a percentage of mice, spontaneous recurrent seizures. It has been shown that administration of pilocarpine induces seizures through the M1-cholinoreceptor M1; however, maintenance of SE involves another mechanism because blocking this receptor after the initiation of SE does not alleviate the condition. 26, 27 Pilocarpine-induced seizures can also be prevented by antiepileptic drugs used for epilepsy treatment in humans, further supporting the pathophysiological relevance of this model. 28 In animal models, H/R and SE have both been shown to cause BBB abnormalities, such as tight junction alterations and increased BBB permeability. 1, 29, 30 However, a complete mechanism by which these disease states lead to BBB opening and its importance are still undefined. In the present study, we demonstrate that in VWF −/− mice, BBB permeability was significantly decreased compared with WT controls in mouse models of H/R and pilocarpine-induced SE. Interestingly, despite having decreased BBB permeability, VWF −/− mice were not protected and even fared worse in both of these models.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

VWF Is Released by H/R
It has been reported that hypoxia induces WPB secretion. 31 To determine the state of endothelial activation in our model of H/R, we analyzed WT mice for plasma VWF antigen levels. Mice that were exposed to 24 hours of hypoxia or 24 hours of hypoxia plus 1 hour of reoxygenation both showed increased VWF antigen levels compared with normoxic controls (normoxia: 99.94±5.73 versus hypoxia: 128.2±12.37 P=0.03; normoxia versus H/R: 146.2±9.16; P<0.001; n=6-11 per group; Figure 1A ). It is possible that the prolonged period of hypoxia may have enhanced VWF synthesis in addition to its known effect on WPB secretion.
VWF
−/− Animals Have Less BBB Permeability Than WT After H/R Cerebral hemispheres of WT and VWF −/− animals were processed to determine the amount of Evan's blue dye bound to albumin that extravasated into the brain after 24 hours of 6% oxygen followed by 1 hour of reoxygenation (H/R). Twoway ANOVA indicated a statistically significant difference between genotype (P<0.001) and condition (normoxia or HR; P<0.001; n=6-9). Student t test revealed that there was significantly less BBB permeability in VWF −/− mice compared with WT controls after H/R (WT: 0.140±0.01; VWF: 0.101±0.001; P<0.001; n=8 per group; Figure 1B) . It was previously reported that VWF −/− mice have a defect in P-selectin translocation to the surface of the endothelium. 32 To determine whether this defect, which could result in reduced early leukocyte recruitment, played a role in the tighter BBB in this model, we inhibited P-selectin in WT mice using a P-selectin aptamer that has been shown to inhibit P-selectin-mediated leukocyte rolling completely ( Figure IA in the online-only Data Supplement). 33 Two-way ANOVA indicated a statistically significant difference between condition (normoxia or HR; P<0.001), but not aptamer treatment (n=4-6). Student t test also revealed that there was no difference between control aptamer-treated mice (WT+control aptamer: 0.184±0.007 Figure 1 . von Willebrand factor (VWF) is released in wild-type (WT) mice after hypoxia/reoxygenation (H/R), and VWF-deficient animals have less blood-brain barrier (BBB) permeability than WT after H/R. A, Endothelial activation was assessed by comparison of plasma VWF levels after hypoxia and H/R with normal mouse plasma (NMP). B, BBB permeability to Evans blue dye in WT and VWF −/− mice exposed to normoxia (room air) or normobaric hypoxia (6% oxygen) for 24 hours followed by 1 hour of reoxygenation. Two-way ANOVA analysis revealed a significant difference between genotype (P<0.001) and condition (P<0.001). Student t test was also used to compare only between genotype. *P<0.001; ***P<0.001. 
WT
VWF −/− Mice Are Not Protected From H/R
The glial-specific S100B leakage into plasma has been previously reported to be an indicator of brain damage. 34 We used Western blotting to assess the extent of S100B leakage into the plasma in WT mice and VWF −/− mice exposed to H/R (Figure 2A ). Our results indicated that significantly more S100B protein was released into the plasma in VWF-deficient mice (P<0.01; n=3-5 per group; Figure 2B ). Degradation of neurofilament proteins has been reported to occur as a result of ischemia. 35, 36 Interestingly, although VWF-deficient animals had much less BBB permeability than WT mice, we did not see protection of neuronal integrity after H/R as assessed by Western blot analysis of neurofilament-70 (NF-70). NF-70 levels were significantly decreased in VWF −/− hippocampi exposed to H/R compared with normoxic animals (P<0.05; n=4 per group; Figure 2D ), whereas we did not find a significant difference between WT normoxic and WT H/R (P=0.224; n=5 per group; Figure 2C ). Immunostaining showed that under normoxic conditions there was no obvious difference in NF-70 immunostaining in the hippocampal region (stratum lacunosum moleculare) of the brain of WT and VWF −/− mice ( Figure IIA and IIB in the online-only Data Supplement), whereas exposure to H/R led to a decrease in staining in both WT and VWF −/− mice in this area of the hippocampus ( Figure   IIC and IID in the online-only Data Supplement). Although there is decreased NF-70 staining in this part of the hippocampus in both WT and VWF −/− mice, the extent of damage throughout the whole hippocampus seems to be much more severe in VWF −/− mice as reflected by Western blots. These data further demonstrate that VWF deficiency was not protective in H/R; on the contrary, it was detrimental.
VWF Is Released by Seizures
We next sought to determine whether the tightness of BBB in VWF −/− mice exposed to H/R could be observed in a separate BBB permeability model. As increased BBB permeability has been proposed to promote the development of SE during pilocarpine-induced seizures, 1 we, therefore, subjected WT and VWF −/− mice to this model. Plasma VWF levels were significantly increased only in mice that had experienced ≥1 seizure, whereas in mice that did not develop major seizures, VWF plasma content remained similar to control level ( Figure 3A ). Endothelial activation seems to be a result of seizure activity and not a side effect of scopolamine or pilocarpine administration, although there was a strong trend toward an increase in VWF levels with . In this experimental group, all VWF-deficient animals had ≥1 seizure, and all died within 120 minutes after pilocarpine administration (data not shown).
Deficiency of Endothelial VWF Increases Susceptibility to Seizures and SE-Induced Mortality
Consistent with previous literature, ≈20% of WT mice did not survive SE.
37 Surprisingly, ≈100% of VWF −/− mice died within 120 minutes after pilocarpine administration. Mice heterozygous for VWF, which have 50% of WT VWF levels, also had a 100% mortality rate ( Figure 4A ). There was a trend toward a decrease in the time to first seizure after pilocarpine administration in VWF −/− and VWF +/− animals compared with WT ( Figure 4B ). All VWF −/− and VWF +/− experienced ≥1 seizure compared with ≈50% in the WT mice, suggesting that mice with decreased VWF levels are more susceptible to pilocarpine-induced seizures and seizure-induced mortality (WT versus VWF −/− , WT versus VWF +/− ; P<0.001; Figure  4C ). Platelets can interact with activated endothelium through VWF-glycoprotein Ibα binding, 38 thus we hypothesized that decreased platelet recruitment to the endothelium during SE might play a role in mortality in VWF −/− mice. To test this hypothesis, we depleted platelets in WT mice. We found no difference in survival time ( Figure 4D ), time to first seizure ( Figure 4E ), or seizure susceptibility ( Figure 4F ) between platelet-depleted and nondepleted mice, indicating that the protective role of VWF in this model is independent of platelet VWF and VWF-platelet interactions. On endothelial stimulation, VWF is released to the endothelial surface and cleaved to circulate in the plasma. To determine whether plasma VWF was protective in this model, we intravenously administered recombinant murine VWF (rmVWF) to VWF −/− mice at the time of pilocarpine administration and again 30 minutes later, which resulted in ≈400% of normal VWF plasma levels ( Figure 4J ). Infusion of rmVWF did not affect survival time ( Figure 4G ), time to first seizure ( Figure 4H ), or seizure susceptibility ( Figure 4I ) in VWF −/− mice. These data indicate that plasma VWF is not protective against SE-induced mortality.
The role of glutamate and N-methyl-D-aspartate receptors is well established in epilepsy, and it has been reported in both mice and humans that N-methyl-D-aspartate receptor antagonism using low dosing of ketamine is protective. [39] [40] [41] To ensure that mortality in VWF −/− mice was the result of seizure activity, we used ketamine to determine whether VWF −/− mice could be rescued during SE. We found that 100% of WT and VWF −/− mice treated with ketamine 20 minutes after pilocarpine survived SE ( Figure 4A ). These data further indicate that mortality in VWF −/− mice is because of seizure activity and is most likely glutamate dependent.
VWF Plays an Inhibitory Role in Claudin-5 Expression
To determine the state of cerebral endothelial tight junction proteins in WT and VWF −/− and VWF +/− mice, we used Western blot analysis of isolated cerebral microvessels. Interestingly, we found a significant increase in claudin-5 expression under baseline conditions in VWF −/− compared with WT (P<0.001; n=5 per group; Figure 5A and 5B). We found no difference in the expression of occludin ( Figure 5A (Figure 5D ), collagen IV+rmVWF ( Figure 5E ), rmVWF ( Figure 5F ), or PBS ( Figure  5G ). Contrary to collagen IV and collagen IV+rmVWF, which grew to confluence in the same time frame, VWF −/− BECs did not grow to confluence on rmVWF, and there were very few adherent cells on glass alone. Collagen IV-and collagen IV+rmVWF-treated plates were kept for 2 days past confluency before being processed for immunostaining and Western blot analysis. Immunostaining for claudin-5 and platelet endothelial cell adhesion molecule-1 revealed that junctional staining of claudin-5 was more intense in the cultures grown on collagen IV alone ( Figure 5H and 5J) compared with cultures grown on collagen IV+rmVWF (Figure 5I and 5K) . We next determined protein levels of claudin-5 and occludin in the cultures treated with collagen IV and collagen IV+rmVWF and found that there was significantly less claudin-5 in cultures grown in the presence of rmVWF ( Figure 5L ; P=0.025; n=5 per group). Culture experiments were repeated, and claudin-5 levels were found again to be significantly lower (col IV: 1.171±0.130 versus col IV+rmVWF: 0.690±0.054; P=0.026; n=3 per group). We found no difference in occludin protein levels in either experiment ( Figure 5M 
Discussion
The goal of this study was to assess the role of VWF in models of disease associated with increased BBB permeability. Pathology of BBB is documented in many central nervous system conditions, and an interesting question in this field is whether or not preventing increased BBB permeability during disease state will be therapeutic. 1, 2, 43 It is well known that hypoxia followed by reoxygenation leads to increased BBB permeability, the mechanisms of which are not entirely understood. 29 Expression and localization of cerebral endothelial cell tight junctions have been shown to be disrupted after H/R. In particular, claudin-5 expression and organization have been shown to be altered because of hypoxic exposure, accompanied by increased BBB permeability. 29, 44 Increased BBB permeability has also been documented in various epilepsy models and in humans with temporal lobe epilepsy. 1, 43, 45 Therefore, it was assumed in both H/R and pilocarpine-induced SE models that preservation of BBB integrity may be therapeutic to the organism. Here, we report that this was not the case. In these 2 models associated with increased BBB permeability, having increased claudin-5 expression in VWF −/− mice at baseline and a tighter BBB than WT during the disease process were not protective.
Inhibition of VWF decreases neutrophil extravasation and permeability in peripheral tissues. 46, 47 Furthermore, a recent study has suggested that VWF plays a regulatory role in cerebrovascular permeability because intraventricular administration of VWF leads to increased BBB permeability as assessed by Evans blue dye leakage. 48 These previous observations and those made here in our work on BBB permeability are in contrast to a report showing increased BBB permeability in VWF −/− mice as a result of immunization with complete Freund's adjuvant and pertussis toxin. 49 We propose that the mechanism of BBB opening that occurs as a result of immunization could be different than that occurring in the models used in our work, resulting in opposite phenotypes.
Previously, it has been reported that hypoxia alone can induce WPB release from endothelial cells. 31, 50 Our results confirm these reports and show that VWF levels remain increased after 1 hour of reoxygenation. New in this study is the finding that seizures activate the endothelium and lead to VWF secretion. One possible mechanism behind this increase is that a WPB secretagogue, such as epinephrine, 51 may be released during seizures. From our results, it seems likely that the VWF released to the basement membrane during seizures has a protective effect for the organism.
It is known that VWF is pivotal for the formation of WPBs in the endothelium. 32 Mice deficient in VWF do not form WPBs, and therefore storage of P-selectin in these mice is impaired, which could potentially play a role in the phenotypes we are reporting. 32 We did not see a difference in BBB permeability between control aptamer-treated and inhibitory P-selectin aptamer-treated WT mice, indicating that P-selectin does not play a major role in BBB permeability in our model of H/R. Also, mortality in the SE model in mice treated with the P-selectin inhibiting aptamer was similar to that of controltreated animals. Another component of WPBs that is associated with BBB permeability is angiopoietin-2. 52 Because of the lack of WPB formation in VWF −/− mice, it is plausible to speculate that decreased BBB permeability in these models is caused by lack of angiopoietin-2 secretion. We do not think that this is the case for 2 reasons. First, it was recently reported that endothelial cells in which VWF is silenced actually secrete more angiopoietin-2 into circulation, possibly because of the lack of storage in WPB. 13 Second, VWF +/− mice have normal WPB formation and demonstrated the same phenotype as VWF null mice during SE. Furthermore, the in vitro effect of recombinant VWF on claudin-5 expression in VWF-deficient endothelial cells also argues against an important role for another WPB component in the claudin-5 regulation process.
We initially anticipated that decreased BBB permeability after H/R would have a protective effect on the brain. Instead, we found increased S100B protein in plasma after H/R in VWF −/− mice. S100B is a Ca
2+
-binding protein that is primarily expressed by astrocytes. 53 Detection of S100B in circulation has been used to reflect brain damage after traumatic brain injury. 34, 54 It has also been suggested that S100B levels in serum may be used to assess BBB permeability. 55 Our findings do not support this because we see less permeability to albumin in stressed VWF-deficient mice compared with WT, but more S100B in the plasma. To further address pathology after H/R, we used NF-70 Western blot analysis of the hippocampus, a region of the brain known to be prone to hypoxiainduced damage. 56 NF-70 is a cytoskeletal protein found in neurons and is used as a marker of neuronal integrity. 36, 57 Western blot analysis of the whole hippocampi revealed a significant decrease of NF-70 in VWF −/− mice. These data, coupled with our S100B data, indicate that brain injury is worse in VWF −/− mice after H/R. A tighter BBB in VWF −/− mice also did not confer protection in the pilocarpine model of SE. Peripheral inflammation has been proposed to play a role in BBB permeability and seizure activity in this model. 1, 3 However, whether seizures cause peripheral inflammation or the opposite is still heavily debated. 43 We have ruled out the potential role for plasma VWF and platelets in protecting mice from mortality associated with VWF deficiency. In light of these data, we propose that it is endothelial, likely subendothelial, VWF that plays a role in decreased permeability in this model. It is known that BBB regulates glutamate transport between the plasma and brain and that epileptics have an increase in brain glutamate. 43, 58 It is evident from our ketamine studies that antagonism of N-methyl-D-aspartate receptors is protective from seizures and mortality in these VWF −/− mice during SE, suggesting that seizure activity is indeed the cause of pathology in VWF −/− animals. Our observation that VWF −/− mice have a tighter BBB and increased baseline levels of claudin-5 led us to propose that their glutamate-dependent mortality in the SE model is because of cerebrovascular dysfunction. Potentially toxic substances produced by the brain during seizure activity, such as glutamate, may be trapped in the brain parenchyma of VWF −/− mice, leading to increased excitation, seizures, and death. Interestingly, hypoxia also leads to excess glutamate release in the brain, and N-methyl-D-aspartate receptor antagonism has been shown to reduce ischemia-induced neuronal cell death. 59, 60 An interesting possibility is that hypoxia contributes to BBB permeability and pathology in mice during seizures. It has been postulated that hypoxia occurs during SE in a rat model and has been shown in a clinical study that oxygen desaturation occurs during seizures. 61, 62 The finding that claudin-5 protein is increased at baseline in VWF −/− animals is intriguing and may explain the lack of BBB flexibility in both models because changes in claudin-5 levels have been shown to alter BBB permeability. 44, 63, 64 The claudin-5 staining is similar to that of zona occluden-1, suggesting that claudin-5 is also localized to the junction in VWF −/− mice. The role of basement membrane proteins in tight junction protein expression is to date underexplored. Importantly, Osada et al 64 have recently reported that the interaction between β1-integrins on endothelial cells and collagen IV in the extracellular matrix plays a role in claudin-5 expression. When this interaction was inhibited, claudin-5 expression was decreased, and BBB permeability to 40 and 150 kDa dextran, as well as IgG, was increased. VWF is a component of the extracellular matrix, 65 and, on endothelial activation, VWF is largely secreted to the basement membrane matrix. 8 We hypothesized that subendothelial VWF may interfere with interactions of collagen IV and endothelial cells, leading to less expression of claudin-5. Indeed, when we cultured VWF −/− BECs on plates treated with collagen IV or collagen IV+rmVWF, we found significantly less claudin-5 protein when VWF was present. Intriguingly, in freshly isolated brain microvessels, we have seen that lack of VWF increased claudin-5 expression by 50% compared with WT. In culture, the absence of basement membrane VWF resulted in an increase in claudin-5 expression by 50% in VWF −/− BECs. The observation that claudin-5 protein is increased in VWF null and also heterozygous animals is especially interesting as we report that both strains of mice have 100% seizure susceptibility and ≈100% mortality during SE. It is plausible that the regulated release of VWF from WPBs modulates the opening of BBB, providing some flexibility to the barrier.
In summary, we report that VWF −/− mice have a tighter BBB than WT when subjected to H/R and pilocarpineinduced SE, likely because of increased claudin-5 protein levels. Unexpectedly, this phenotype did not confer protection in either of these models and seems to actually be detrimental to the animal. Our study suggests that normal regulation of BBB permeability is important under stressful conditions and that tightening BBB may not always be a suitable therapy for diseases involving barrier opening. 
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